HHS Recommends DEA Reschedule Cannabis to Schedule III

By Cannabis Industry Journal Staff
No Comments

In a historic move for the industry, the Biden Administration sent a letter to the DEA, recommending that the federal agency remove cannabis from Schedule I and reclassify it as Schedule III, removing it from the list of drugs with no medical value and high potential for abuse. If this recommendation results in a rescheduling, the implications for the cannabis industry could be enormous.

Continue reading